Publications
Specialty
Search
Pharmacy Learning Network
05/30/2024
Hospitalized older adults with respiratory syncytial virus (RSV) often have acute cardiac events that are associated with severe clinical outcomes, according to a study published in JAMA Network Open.
First Report Managed Care
05/30/2024
Rosacea imposes a substantial burden on both patients and the economy, and further research is needed to better understand its pathogenesis and develop new treatments, according to an article published in Frontiers in Medicine.
Vascular Disease Management, CardioVascular
05/30/2024
The case for physician-modified endografts in urgent settings was made by Nikolaos Tsilimparis, who spoke about an important multicenter trial on physician-modified endografts in complex aortic surgery.
Vascular Disease Management, CardioVascular, Cath Lab Digest
05/30/2024
The clinical realities of big trials such as BEST-CLI and BASIL-2 were dissected by Dr. Tatsuya Nakama in a session that explored strategic visions for the future of below-the-knee interventions.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
05/30/2024
The precision coaching program led to an increase in participants achieving BP control and a decrease in participants with stage 2 hypertension. The study also highlighted high participant engagement and minimal need for manual clinician outreach.
EP Lab Digest
05/30/2024
May 29, 2024 09:00 AM Eastern Daylight Time—VANCOUVER, British Columbia--Kardium Inc., a private medical device company that has developed the
EP Lab Digest
05/30/2024
Conference focuses on rapidly expanding field of sports cardiology and increasing demand for CV care teams who care for athletes
Oncology
05/30/2024
Pelabresib plus ruxolitinib significantly reduced splenomegaly and improved anemia and bone marrow fibrosis compared with placebo plus ruxolitinib among JAK-inhibitor-treatment-naïve patients with myelofibrosis, according to updated phase 3 results presented at the 2024 ASCO Annual meeting.
Vascular Disease Management, CardioVascular
05/30/2024
The latest results from the LUMIFOLLOW trial—a prospective, multicenter, consecutive, post-market study of the Luminor drug-eluting balloon (DCB; iVascular) in the treatment of femoropopliteal lesions—was discussed by Eric Ducasse, Professor and Head Vascular Surgery at the University of Bordeaux, France.
EP Lab Digest
05/30/2024
CRANBURY, N.J.--Rocket Pharmaceuticals, Inc., a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, announced that the European Commission (EC), based on a positive opinion issued by the
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
05/30/2024
New York — A survey recently conducted on behalf of Medtronic and in partnership with the National Kidney Foundation (NKF), the largest kidney organization in the U.S., found that physicians are seeking new approaches to lowering patients’ blood pressure.
EP Lab Digest
05/29/2024
St. Louis, May 29, 2024 – Stereotaxis, a pioneer in surgical robotics for minimally invasive endovascular intervention, today announces the successful treatment of the first heart rhythm patients by Penn Presbyterian Medical Center (PPMC) utilizing the advanced Genesis Robotic Magnetic Navigation System.
First Report Managed Care
05/29/2024
Learn about promising drugs currently in the pharmaceutical pipeline and the impact of FDA interventions from presenters at AMCP 2024.
Vascular Disease Management, CardioVascular, Cath Lab Digest
05/29/2024
Preliminary results from a systematic literature review on the use of atherectomy for infrainguinal peripheral artery disease were presented on Tuesday by angiologist Ralf Langhoff.
Annals of Long-Term Care
05/29/2024
A group of nursing home residents in Maryland filed a class action lawsuit against the state health department for failing to meet requirements calling for annual inspections of skilled nursing facilities (SNFs), McKnights Long-Term Care News recently reported.
Pharmacy Learning Network
05/29/2024
At the end of April 2024, the US Department of Health and Human Services (HHS) released final amendments to the Health Insurance Portability and Accountability Act (HIPPA) Privacy Rule. The amendments further protect the privacy of protected health information (PHI) related to reproductive health. The final amendments were published in the Federal Register on April 26, 2024, meaning the deadline for compliance with the new amendments will be late December 2024.
Wound Care
05/29/2024
All seven MACs, in a united front, released proposed changes to the LCDs, which govern Skin Substitute/CTP use for DFUs and VLUs. SmartTRAK looks at the potential impact on the market.
First Report Managed Care
05/29/2024
Researchers present a case study of a 53-year-old woman who was misdiagnosed with multiple sclerosis (MS) and experienced adverse effects after receiving the immunotherapy intravenous immunoglobulin (IVIG).
Vascular Disease Management, CardioVascular
05/29/2024
An introduction to a new trial focused on aggressive vessel preparation took center stage on Wednesday as part of a ‘last frontiers’ session tackling severely calcified lesions. Tim Wittig detailed the CRACK-IT trial.
Vascular Disease Management, CardioVascular
05/29/2024
Quality of life assessments were explored in detail on Tuesday morning by Oliver Schlager, who talked about the severity of venous insufficiency and post-thrombotic syndrome, which are typically assessed by the Villalta scale.